Sherman, M <br/><br/>
Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy.  [electronic resource] 

 -  Gut  Nov 2006 
 - 1631-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0017-5749 
<br/><br/><label>Standard No.: </label>10.1136/gut.2005.083113  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--adverse effects<br/>Drug Therapy, Combination<br/>Female<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--adverse effects<br/>Male<br/>Middle Aged<br/>Patient Dropouts<br/>Polyethylene Glycols--adverse effects<br/>Recombinant Proteins<br/>Ribavirin--adverse effects<br/>Treatment Failure<br/>Treatment Outcome